Episode 820 · November 12, 2026

The Evolving Understanding of Periodontal Disease

Listen on your favorite platform

Leave a review ↓
Apple PodcastsSpotifyYouTubeiHeart

Featured Guest

Dr. Phil Klein

Dr. Phil Klein

View profile →

Endodontist · Host of the Dr. Phil Klein Dental Podcast

University of Pennsylvania School of Dental Medicine

Read full bio

Dr. Philip Klein has over 40 years of experience in the dental profession including private practice, education and industry. Dr. Klein attended the University of Pennsylvania College of Engineering and Applied Science, where he earned a Bachelor of Applied Science degree. He then went on to earn his DMD degree from Penn Dental, spent a year internship at Graduate Hospital and then earned his Post-Doctorate specialty degree in Endodontics from Penn Dental in 1985. Dr. Klein was in private practice as an Endodontic specialist for fourteen years in Philadelphia, Pennsylvania.

In 1994 Dr. Klein founded and served as President and CEO of Dental Logics Inc., a research and development company specializing in endodontic and restorative products. At Dental Logics Dr. Klein patented and developed a new post system and composite material designed to repair compromised teeth. Both products were subsequently sold to an international dental company, Premier Dental Products Company. Dr. Klein currently holds three dental patents, including the IntegraPost System.

In 1999 Dr. Klein founded and served as CEO of Learn HealthSci Inc., a San Diego-based company specializing in live and on-demand streaming media using Flash Media Server and Real Player. Through the technology he developed, he was one of the earliest companies to broadcast live learning via the Internet which paved the way for Viva Learning, LLC, now the largest dental CE entity in the world.

In 2006, Dr. Klein founded Viva Learning LLC, a global e-learning company based in Austin Texas where he currently serves as Chairman of the Board. He is actively involved in new product development and technology innovation and hosts The Phil Klein Dental Podcast Show which draws more than 30,000 listens per month. With a user base of over 460,000 dental professionals, Viva Learning LLC has taken a global leadership position in Internet-based continuing education for the dental profession.

Episode Summary

What if the way you've been explaining periodontal disease to your patients is only half the story — and that gap is quietly undermining their long-term outcomes?

This episode is hosted by Dr. Phil Klein, DMD, an endodontist and entrepreneur with over 40 years of experience spanning private practice, dental education, and the dental industry. Dr. Klein earned his Bachelor of Applied Science from the University of Pennsylvania College of Engineering, his DMD from Penn Dental, and his post-doctoral specialty certificate in Endodontics from Penn Dental in 1985. He holds three dental patents, founded Viva Learning LLC — now the largest dental continuing education entity in the world with over 460,000 dental professional users — and hosts a podcast that draws more than 30,000 listens per month.

In this episode, Dr. Klein delivers a focused clinical and scientific overview of how the understanding of periodontal disease has fundamentally shifted — from a bacterial infection model to a biofilm-mediated inflammatory disease framework. He walks through the microbiology of dysbiosis, the role of the host immune response in driving tissue destruction, and the 2017 World Workshop classification system that now defines disease by stage and grade. The discussion directly translates this evolving science into practical guidance for the general dentist, covering early detection, risk stratification, patient communication, and the oral-systemic connection.

Episode Highlights:

  • Periodontal disease is now understood as a biofilm-mediated inflammatory condition rather than a simple bacterial infection. The subgingival environment functions as a complex microbial ecosystem, and it is the dysbiosis — or imbalance — of that microbial community, not a single invading pathogen, that drives disease progression.
  • The host immune response is a primary driver of periodontal tissue destruction, not merely a reaction to it. Inflammatory mediators including cytokines, prostaglandins, and enzymes that are released to fight infection simultaneously damage the surrounding connective tissue and alveolar bone — meaning much of the clinical destruction observed is host-mediated.
  • The 2017 World Workshop on the Classification of Periodontal and Peri-Implant Diseases introduced a staging and grading system that gives clinicians a more complete clinical picture. Stage reflects the severity of existing damage across four levels, while Grade A through C characterizes the rate of disease progression — with Grade C indicating rapid advancement often disproportionate to plaque levels and associated with a dysregulated immune response.
  • For the general dentist, this modern framework changes how periodontal disease should be communicated to patients and managed long term. Reframing perio as a chronic inflammatory condition — analogous to hypertension or diabetes — rather than a one-time infection helps set realistic expectations, positions maintenance therapy as essential, and improves patient compliance and clinical outcomes.
  • Systemic risk factors including smoking, uncontrolled diabetes, stress, sleep quality, and glycemic control all influence inflammatory pathways that accelerate periodontal breakdown. Emerging diagnostic tools such as microbial testing, salivary diagnostics, and host response biomarkers may soon allow earlier identification of high-risk patients and more precisely tailored treatment strategies.

Perfect for: General dentists, dental hygienists, and periodontal residents seeking a clinically grounded update on the science of periodontal disease, its modern classification, and how evolving knowledge translates into everyday patient care decisions.

If you've ever struggled to explain why two patients with similar plaque levels have wildly different outcomes, this episode gives you both the science and the language to close that gap.

Transcript

Read Full Transcript

This transcript was automatically generated and may contain errors or inaccuracies. It is provided for reference and accessibility purposes and may not represent the exact words spoken.

The immune response, the release of cytokines, prostaglandins, and enzymes, they're designed to fight infection. But in doing so, those inflammatory mediators also damage the surrounding connective tissue and bone. In other words, much of the tissue destruction we see clinically in periodontal disease is host-mediated. That understanding led to a major shift in periodontal science. and ultimately influenced the classification systems used today. Welcome to Austin, Texas, and welcome to the Dr. Phil Klein Dental Podcast. Before we jump into today's conversation, we've got a quick favor to ask. If you're enjoying the show, hit that follow button, whether it's Apple, Spotify, or whatever platform you use. And if you really want to help us out, leave us a review. It only takes a minute. It helps us reach more dental professionals, bring you more incredible guests, and keep the conversations coming. We really do appreciate it. If you've been practicing dentistry for any length of time, you've probably noticed that the way we talk about perio disease has slowly changed. Years ago, the explanation felt simple. Perio disease was described as an infection. Bacteria accumulate around the teeth, inflammation follows, bone is lost, and eventually teeth are compromised. Now, that model wasn't wrong, but it also wasn't the full story. Today, the science around periodontal disease has evolved quite a bit, and with that evolution has come a shift in how we define and manage the condition. Increasingly, periodontal disease is being described not simply as an infection, but as a biofilm -mediated inflammatory disease. And that change in language actually reflects a much deeper understanding of what's really happening in the tissues surrounding our patient's teeth. So in this episode, I want to take a few minutes to walk through how our understanding of period disease has evolved. That's number one. And number two, why that matters. And then, of course, number three, the big number three, what it means for the general dentist in everyday clinical practice. So for many decades, periodontal disease was viewed primarily through the lens of infection. The model was fairly straightforward. Dental plaque accumulates on the teeth. That plaque contains bacteria. Those bacteria release toxins that irritate the surrounding gingival tissues, inflammation follows, and if the process continues, it eventually leads to destruction of the periodontal ligament and alveolar bone, the attachment apparatus. And also for many decades, the treatment approach reflected that understanding. If bacteria are causing the problem, the goal becomes removing bacteria. Hence, scaling and root planing, plaque control. antimicrobial rinses, improved oral hygiene. And to be clear, those interventions remain foundational to periodontal therapy today. But as microbiology advanced and researchers began studying the oral environment in greater detail, it became clear that the story was more complicated than simply bacteria-caused disease. One of the major turning points came with a deeper understanding of dental biofilm. Hence the biofilm revolution. Dental plaque is not just a random collection of bacteria. It's an organized, highly structured community of microorganisms that live together in what scientists call a biofilm. Within this biofilm, bacteria communicate with one another, share nutrients, and coordinate behavior in ways that make them far more resilient than individual organisms floating freely in saliva. This concept completely changed how we think about microbial infections in many areas of medicine, including dentistry. Inside a biofilm, bacteria behave differently than they do in isolation. They become more resistant to antimicrobials. They create protective extracellular matrices, and they adapt dynamically to the environment. In the context of periodontal disease, This means the subgingival environment is not simply colonized by a few harmful bacteria, as I said before. Instead, it becomes an ecological system in which the balance of microbial species shifts over time, and that shift is known as dysbiosis. One of the key insights in modern periodontal research is that periodontal disease is not necessarily caused by a single pathogen invading healthy tissue. Instead, it's the imbalance of the microbial community that drives disease progression. That's really important, that imbalance of the microbial community. Again, that's dysbiosis. In a healthy mouth, the oral microbiome contains hundreds of bacterial species that coexist in a relatively stable equilibrium. But when that equilibrium is disrupted because of plaque accumulation, host susceptibility, or environmental factors, certain pathogenic organisms begin to dominate. Among the most studied are organisms like Porphyromonas gingivalis, Troponema denticola, and Tanarella forsythia. These bacteria are often referred to collectively as the red complex, but even these organisms don't act alone. One of the fascinating concepts that emerged from periodontal research is that some pathogens act as keystone organisms. They may not be present in large numbers, but they can alter the host immune response and reshape the microbial ecosystem in ways that allow other harmful bacteria to flourish. So again, the disease process is not simply infection. It's a microbial imbalance interacting with the host immune system. And that brings us to the second half of the modern definition, inflammation. One of the reasons periodontal disease behaves so differently among patients is that the host response, the host immune response, varies dramatically from person to person. You've probably seen this in your own practice. Two patients present with similar plaque levels. One develops deep pockets and bone loss, and the other shows minimal destruction. Why? Because periodontal destruction is not caused solely by bacteria. It's largely driven by the body's inflammatory response. to those bacteria. In dental school, my pathology teacher gave us an example of looking, he told us to look under our nails. And if you see dirt under your nails, why don't you see inflammation? Why don't you see swelling? Because the body is not responding to that bacteria that's under your nails. But if you took that same bacteria, for instance, and put it somewhere else in your body, you might have a very robust immune response. And it's the immune response. the release of cytokines, prostaglandins, and enzymes. They're designed to fight infection. But in doing so, those inflammatory mediators also damage the surrounding connective tissue and bone. In other words, much of the tissue destruction we see clinically in periodontal disease is host-mediated. That understanding led to a major shift in periodontal science and ultimately influenced the classification systems used today. Before we get back to our podcast, I want to take a moment to thank our sponsor, EMS, the company behind guided biofilm therapy, or GBT. If you haven't heard of it, GBT was developed with leading universities and clinicians, and it's quickly becoming the gold standard for managing biofilm. What makes it so effective is the minimally invasive evidence-based approach. With airflow, perioflow, and piezon technologies, GBT gently removes biofilm, stains, and calculus with impressive precision. Patients really notice the comfort and speed, and hygienists love how efficient the workflow becomes. No surprise that thousands of practices worldwide are already seeing great results. And EMS makes it easy to bring GBT into your practice with clinical guidance, marketing support, and a clear plan for implementation. So check out the GBT-ready practice setup at gbt-shop.us. So let's get into the modern definition. Today, periodontal disease is widely described, as I mentioned, as a biofilm-mediated inflammatory disease of the supporting structures of the teeth. the attachment apparatus. That language emphasizes three key elements. First, biofilm, meaning the disease originates from a structured microbial community rather than isolated bacteria. Second, inflammation, meaning the host immune response plays an essential role in tissue destruction. And third, susceptibility, meaning systemic and behavioral risk factors influence disease progression. Now, this modern framework of these three things that I just mentioned was reflected in the global periodontal classification system introduced at the 2017 World Workshop on the classification of periodontal and peri-implant diseases and conditions. Here's what was established at that workshop. Instead of older labels, we now break it into two key pieces, stage and grade. Think of stage as how much damage has already been done. and grade as how fast the disease is progressing. It gives clinicians a much clearer, more complete picture of what's happening with the patient. So let's walk through the stages. Stage 1 is early disease, minor attachment loss, minimal bone loss, and very manageable. Stage 2 steps that up to moderate disease, with deeper pockets and more noticeable bone loss. Then you get into stage 3, where things become severe, significant attachment loss. deeper defects, and even some tooth loss. Finally, stage four is the most advanced, where not only is there severe destruction, but you're also dealing with functional issues like bite collapse, drifting teeth, and need for complex rehabilitation. Now the grading adds another layer. Grade A is slow-moving disease. Grade B is what we'd consider typical progression. And grade C is where things get really interesting and concerning. These are the fast movers. When you diagnose a patient at stage 3 or 4 with grade C, you're not just saying the disease is advanced. You're saying it's progressing rapidly, often out of proportion to plaque levels. And that's where the biology shifts. In these situations, we're seeing a hyper-inflammatory or dysregulated immune system, where the patient's own response is driving much of the destruction. And that's why these cases require closer monitoring and often a more aggressive, tailored treatment approach. So here's the big question. Why does this shift in understanding matter for GPs? Because it changes how we approach prevention, diagnosis, and long-term management. First, it reinforces that periodontal disease is chronic and multifactorial. Scaling and root planing can reduce bacterial load. But long-term stability requires controlling the factors that drive inflammation. That means looking at the whole patient. Smoking status, metabolic health, glycemic control, stress, sleep. All of these influence inflammatory pathways that can accelerate periodontal breakdown. Second, it changes how we communicate with patients. If patients believe periodontal disease is just an infection, They may assume, rightfully so, that a single deep cleaning will fix it. But when we explain that it's an inflammatory condition influenced by their immune response, it reframes the conversation. Now it becomes more of a partnership that they can help manage with us long term, much like hypertension or diabetes. And that perspective often improves patient compliance and ultimately clinical outcomes. So let's talk about some practical takeaways for the GP. One of the most important is early detection. Because periodontal disease is often painless, many patients don't realize anything is wrong until significant attachment loss has already occurred. We see that all the time in the office. Routine periodontal charting, radiographic evaluation, and careful assessment of bleeding on probing remain essential tools. Bleeding in particular is a powerful clinical indicator. Healthy gingiva should not bleed with gentle probing. Persistent bleeding is often a sign that inflammatory processes are active beneath the surface. Another practical application involves risk assessment. Patients who smoke, have uncontrolled diabetes, or demonstrate a history of rapid attachment loss may require more aggressive monitoring and shorter recall intervals. We'll be right back in a second, but first, for many years now, we've recognized that buffering local anesthetics can reduce injection pain, speed up onset, and decrease the overall volume of anesthesia needed. However, the process of buffering has always been complex, time-consuming, and expensive. Until now. Introducing BufferPro. a single-use, sterile, self-contained capsule that delivers 0 .1 mils of sodium bicarbonate into a dental anesthetic cartridge, raising the solution's pH to near physiologic levels. No measuring, no mixing, and no hassle. Join the growing number of dentists introducing BufferPro into their practices. To learn more, visit septodontusa.com. And these patients can benefit from close collaboration between general dentists and periodontal specialists. And of course, maintenance therapy becomes critical because biofilm reforms quickly. Periodontal stability often depends on consistent disruption of that biofilm through professional cleanings, specific equipment that you can purchase for your office, and of course, effective home care. And of course, we can't have this discussion without bringing up the oral systemic connection. And that's another reason periodontal disease is receiving so much attention today. in its potential connection to systemic health. Research in periodontology and systemic medicine continues to explore links between periodontal inflammation and conditions like cardiovascular disease, diabetes, adverse pregnancy outcomes, respiratory disease, and so forth. So while cause and effect relationships are still being studied, the association between periodontal inflammation and systemic inflammatory burden is becoming increasingly clear. That places dentistry in an interesting position. For many patients, the dental office may be the only health care setting where chronic inflammation is detected early, which means dentists and hygienists play a critical role, not only in oral health, but in the overall health awareness of the patient. So what is the future of periodontal care? As our understanding of periodontal disease continues to evolve, New diagnostic and treatment approaches are emerging, things like microbial testing, salivary diagnostics, host response biomarkers, and therapies that target inflammation rather than just bacteria. These advances may eventually allow dentists to identify high-risk patients earlier and tailor treatment strategies more precisely. But even with all the technology on the horizon, the fundamentals remain remarkably consistent. Control biofilm, reduce inflammation, address risk factors, and maintain long-term periodontal stability through ongoing care. So here are my final thoughts on this. At its core, perio disease is a fascinating example of how medicine evolves. What once seemed like a straightforward infection is now understood as a complex interaction between microbes, the immune system, and environmental influences. And that deeper understanding ultimately benefits patients because when dentists view perio disease, as a biofilm-mediated inflammatory condition, the focus shifts from simply treating pockets to managing health over time. For the general dentist, that means continuing to emphasize early detection, patient education, risk assessment, and collaborative care, not only with periodontists, but with the patient's physicians. And perhaps most importantly, it reminds us that the tissues supporting the teeth are part of a much larger biological system, one that reflects and is deeply connected to the patient's overall health. So that's it for today, folks. Thank you so much for listening. I'm Dr. Phil Klein. See you next time.

Clinical Keywords

periodontal diseasebiofilm-mediated inflammationdysbiosishost immune responsecytokinesprostaglandinsperiodontal classification2017 World Workshopstaging and gradingPorphyromonas gingivalisTreponema denticolaTannerella forsythiared complexkeystone pathogensscaling and root planingbleeding on probingattachment lossalveolar bone lossoral systemic connectionsalivary diagnosticsmicrobial testingguided biofilm therapyGBTEMSBufferProsodium bicarbonate bufferingSeptodontDr. Phil KleinDr. Philip KleinViva Learningdental podcastdental educationperiodontal maintenancerisk assessment

Related Episodes

Rate This Episode

Share your feedback with the dental community. Reviews are moderated before appearing on the site.

★★★★★
0/1000

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.